Twitter universal website tag code Twitter website tag code

[Skip to content]

Private hospital continually investing in advanced diagnostic and treatment technologies
Search our Site

Clinical Oncologist Stephen Morris, Private Clinic Treatment, Self Pay Patients

Dedicated GP referral service

Call Cromwell Direct to make a referral on

+44 (0)800 783 9229

More about Cromwell Direct

Make a referral

Refer a patient to us by telephone, fax or email

How to refer

Make an appointment

8am-8pm Monday to Friday
8am-2pm Saturday
Call our Contact Centre on

+44 (0)20 7460 5700

Contact Us

Dr Stephen Morris, Consultant Clinical Oncologist

Specialising in:

Urological cancers (with a special interest in brachytherapy and external beam radiotherapy for prostate cancer). 
Skin cancers (with a specialist interest in primary cutaneous lymphoma)

(Unnamed Fieldset)
Specialist Details
Full name

Dr Stephen Morris

Qualifications

MBBS MRCP FRCR

Title

Consultant Clinical Oncologist

Specialties

Oncology - clinical (radiation)

Site specialisation

Urological and skin (lymphoma)

Site specialisation 2
Clinical interests

Urological cancers (with a special interest in brachytherapy and external beam radiotherapy for prostate cancer). 
Skin cancers (with a specialist interest in primary cutaneous lymphoma)

Background Information
Biography
Languages spoken

English

Availability
Regular Cromwell clinics

Yes

Clinic days

Mon: Tue: Wed: Thurs: am/pmFri: Sat:

Appointments telephone number

020 7460 5700

Additional Career Information
Year qualified

1995

Memberships

Royal College of Radiologists 
British Institute of Radiology 
British Medical Association

NHS hospitals

Guy's/King's/St Thomas'

Posts
Research interests

Urological Cancer (Dynamic dose feedback Prostate Brachytherapy, Modern techniques and Image guidance for External Beam Radiotherapy) 
Skin Cancers (Total Skin Electron Beam Radiotherapy, Chemotherapy and new biological therapies)

Key published papers

Morris SL. Skin Lymphoma. Clin Oncol (RCR) 2012 Jun;24 (5):371-85 
Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A WebbK Scarisbrick J, Morris S, Whittaker SJ. Survival Outcomes and Prognostic factors in Mycosis Fungoides/Sezary Syndrome: Validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Reseach and Treatment of Cancer Staging Proposal. J Clin Oncol 2010 Nov 1;28(31); 4730-9 
Acher P, Popert R, Nichol J, Potters L, Morris S, Beaney R. Permanent prostate brachytherapy: Dosimetric results and analysis of a learning curve with a dynamic dose-feedback technique. Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):694-8. Epub 2006 Apr 19 
Morris SL, Low SH, A'Hern RP, Eisen TG, Gore ME, Nutting CM, Harrington KJ. A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. Br J Cancer. 2004 Aug 31;91(5):829-33. 
Morris SL, Parker C, Huddart R, Horwich A, Dearnaley D. Current opinion on adjuvant and salvage treatment after radical prostatectomy. Clin Oncol (R Coll Radiol). 2004 Jun;16(4):277-82.

Website

Media coverage

Our consultants regularly contribute to hospital publications, as well as national newspaper articles and television coverage.